{"symbol":"ABT","fiscalQuarter":"Q3-2016","reportDate":"2016-10-19","reportTime":"BMO","status":"reported","company":{"name":"Abbott Laboratories","sector":"Health Care","industry":"Health Care Equipment"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/ABT/earnings/Q3-2016","postBrief":{"headline":"Abbott Laboratories Beats on EPS, Stock Down 2.82%","keyNumbers":[{"metric":"EPS","actual":"$0.59","expected":"N/A","surprise":"+1.55%"},{"metric":"Revenue","actual":"N/A","expected":"N/A","surprise":"N/A"}],"managementCommentary":{"tone":"Unknown","keyQuotes":[],"summary":"No transcript is on record, and the analysis is based on numerical results only."},"guidanceChanges":{"summary":"No guidance data is available.","changes":[]},"whatItMeans":"Abbott Laboratories reported an EPS that exceeded expectations, but the stock fell by 2.82% in reaction. This decline may reflect investor concerns or broader market trends, as there was no revenue figure provided and no guidance updates were shared.","metaDescription":"Abbott Laboratories (ABT) Q3 2016 earnings: EPS beat by 1.55%. Stock down 2.82%. Full breakdown."}}